Picture courtesy uk.news.yahoo.com
New Delhi: The central government’s Subject Expert Committee (SEC) is likely to meet on Wednesday on drugmaker Dr. Reddy’s application seeking emergency use authorisation for the Sputnik V vaccine in India. If the SEC gives a nod, Sputnik V will be India’s third vaccine after Covaxin and Covishield, News18 reported.
Dr. Reddy’s has partnered with the Sputnik V vaccine to run clinical trials in India. It had submitted the immunogenicity data after a meeting that was held on February 24.
Dr Reddy’s has partnered with Russia Direct Investment Fund (RDIF) to bring the Sputnik V vaccine to India. The Russian vaccine has shown an efficacy of 91.6 %.
Stay ahead with Odisha Bytes Breaking News - your ultimate source for the fastest, most… Read More
Bhubaneswar: The Odisha Police Recruitment Board (OPRB) has postponed the upcoming examination for Group B… Read More
Bhubaneswar: The Supreme Court Collegium has recommended the appointment of Justice Harish Tandon as the… Read More
Bhubaneswar: Two senior IAS officers of Odisha cadre – Ranjana Chopra and Santosh Kumar Sarangi… Read More
Bhubaneswar: Skygazers are in for a treat as the spectacular total lunar eclipse, also known… Read More
Lucknow: An ‘active terrorist’ of Babbar Khalsa International (BKI), who allegedly has ties with Pakistan’s… Read More
This website uses cookies.
